Curis Lifesciences Limited (NSE:CURIS)

Curis Lifesciences Revenue

In the fiscal year ending March 31, 2025, Curis Lifesciences had annual revenue of 496.32M INR with 39.59% growth. Curis Lifesciences had revenue of 127.24M in the quarter ending March 31, 2025.

• Revenue: 496.32M
• Revenue Growth: +39.59%
• P/S Ratio: 2.02
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.00B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	496.32M	140.77M	39.59%
Mar 31, 2024	355.56M	1.07M	0.30%
Mar 31, 2023	354.49M	117.04M	49.29%
Mar 31, 2022	237.45M	24.85M	11.69%
Mar 31, 2021	212.60M	75.67M	55.26%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 25, 2026

Data Sources Report a data error